OneOncology has announced that is is entering a long-term strategic relationship with AmerisourceBergen to offer high-quality cancer care to patients across the country.
OneOncology has announced that is is entering a long-term strategic relationship with AmerisourceBergen to offer high-quality cancer care to patients across the country. OneOncology chose ION Solutions and Oncology Supply to offer a suite of services and solutions to community practices across the country. ION Solutions has been chosen for group purchasing organization contracting and Oncology Supply has been selected for the distribution of chemotherapy and supportive care products to OneOncology members.
“We look forward to a collaborative relationship with AmerisourceBergen that delivers value to all of our stakeholders,” said Jeffrey Patton, MD, president of Physician Services at OneOncology and chief executive officer of Tennessee Oncology, a OneOncology practice. “We believe this strategic partnership will help to optimize clinical and financial efficiencies for all of our partners during an era of unprecedented innovation in oncology.”
What Will AI in Health Care Look Like in the Future?
July 10th 2025Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and shaping future health care training, as discussed by experts at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More
Practical Considerations for AI in Community Oncology
July 8th 2025Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."
Read More
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More